{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:40:41Z","timestamp":1781638841355,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T00:00:00Z","timestamp":1645401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Zhejiang Medicine & Health Technology Project","award":["2018KY869"],"award-info":[{"award-number":["2018KY869"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10096-022-04423-6","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:13:10Z","timestamp":1645477990000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Risk factors for antibiotic resistance and mortality in patients with bloodstream infection of Escherichia coli"],"prefix":"10.1007","volume":"41","author":[{"given":"Shunjin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"issue":"3","key":"4423_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304\u2013377. https:\/\/doi.org\/10.1007\/s00134-017-4683-6","journal-title":"Intensive Care Med"},{"issue":"4","key":"4423_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1128\/CMR.00002-14","volume":"27","author":"KB Laupland","year":"2014","unstructured":"Laupland KB, Church DL (2014) Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 27(4):647\u2013664. https:\/\/doi.org\/10.1128\/CMR.00002-14","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"4423_CR3","doi-asserted-by":"publisher","first-page":"e013665","DOI":"10.1136\/bmjopen-2016-013665","volume":"7","author":"N Buetti","year":"2017","unstructured":"Buetti N, Atkinson A, Marschall J, Kronenberg A, the Swiss Centre for Antibiotic Resistance (ANRESIS) (2017) Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008\u20132014. BMJ Open 7(3):e013665. https:\/\/doi.org\/10.1136\/bmjopen-2016-013665","journal-title":"BMJ Open"},{"issue":"7","key":"4423_CR4","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh P-R, Mendes RE, Pfaller MA, Rolston KV, Sader HS et al (2019) The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 63(7):e00355\u2013e00319. https:\/\/doi.org\/10.1128\/AAC.00355-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"4423_CR5","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000203","volume":"4","author":"C Branger","year":"2018","unstructured":"Branger C, Ledda A, Billard-Pomares T, Doublet B, Fouteau S, Barbe V et al (2018) Extended-spectrum \u03b2-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins. Microb Genom 4(9):e000203. https:\/\/doi.org\/10.1099\/mgen.0.000203","journal-title":"Microb Genom"},{"issue":"35","key":"4423_CR6","doi-asserted-by":"publisher","first-page":"30329","DOI":"10.2807\/1560-7917.ES.2016.21.35.30329","volume":"21","author":"S Bou-Antoun","year":"2016","unstructured":"Bou-Antoun S, Davies J, Guy R, Johnson AP, Sheridan EA, Hope RJ (2016) Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to march 2014. Eurosurveillance 21(35):30329. https:\/\/doi.org\/10.2807\/1560-7917.ES.2016.21.35.30329","journal-title":"Eurosurveillance"},{"issue":"3","key":"4423_CR7","doi-asserted-by":"publisher","first-page":"251.e1","DOI":"10.1016\/j.cmi.2015.01.001","volume":"21","author":"JK Abernethy","year":"2015","unstructured":"Abernethy JK, Johnson AP, Guy R, Hinton N, Sheridan EA, Hope RJ (2015) Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England. Clin Microbiol Infect Dis 21(3):251.e1\u2013251.e8. https:\/\/doi.org\/10.1016\/j.cmi.2015.01.001","journal-title":"Clin Microbiol Infect Dis"},{"issue":"10","key":"4423_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.cmi.2018.01.013","volume":"24","author":"M Giannella","year":"2018","unstructured":"Giannella M, Pascale R, Toschi A, Ferraro G, Graziano E, Furii F et al (2018) Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-Centre study. Clin Microbiol Infect 24(10):1077\u20131083. https:\/\/doi.org\/10.1016\/j.cmi.2018.01.013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"4423_CR9","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1038\/s41598-018-33246-9","volume":"8","author":"C Mewes","year":"2018","unstructured":"Mewes C, B\u00fcttner B, Hinz J, Alpert A, Popov AF, Ghadimi M et al (2018) The CTLA-4 rs231775 GG genotype is associated with favorable 90-day survival in Caucasian patients with sepsis. Sci Rep 8(1):15140. https:\/\/doi.org\/10.1038\/s41598-018-33246-9","journal-title":"Sci Rep"},{"key":"4423_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662171","volume":"12","author":"V Matzaraki","year":"2021","unstructured":"Matzaraki V, Le KTT, Jaeger M, Aguirre-Gamboa R, Johnson MD, Sanna S et al (2021) Inflammatory protein profiles in plasma of candidaemia patients and the contribution of host genetics to their variability. Front Immunol 12:662171. https:\/\/doi.org\/10.3389\/fimmu.2021.662171","journal-title":"Front Immunol"},{"issue":"2","key":"4423_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00011-019-01301-4","volume":"69","author":"T Varljen","year":"2020","unstructured":"Varljen T, Sekulovic G, Rakic O, Maksimovic N, Jekic B, Novakovic I et al (2020) Genetic variant rs16944 in IL1B gene is a risk factor for early-onset sepsis susceptibility and outcome in preterm infants. Inflamm Res 69(2):155\u2013157. https:\/\/doi.org\/10.1007\/s00011-019-01301-4","journal-title":"Inflamm Res"},{"issue":"12","key":"4423_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/annonc\/mdu451","volume":"25","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Ji XW, Hou XM, Lu FM, Du Y, Yin JH et al (2014) Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma. Ann Oncol 25(12):2413\u20132419. https:\/\/doi.org\/10.1093\/annonc\/mdu451","journal-title":"Ann Oncol"},{"issue":"1","key":"4423_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/jac\/dkw372","volume":"72","author":"J Quan","year":"2017","unstructured":"Quan J, Zhao D, Liu L, Chen Y, Zhou J, Jiang Y et al (2017) High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother 72(1):273\u2013280. https:\/\/doi.org\/10.1093\/jac\/dkw372","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"4423_CR14","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/jac\/dks082","volume":"67","author":"I Schlackow","year":"2012","unstructured":"Schlackow I, Nicole Stoesser A, Walker S, Crook DW, Peto TEA, Wyllie DH (2012) Infections in Oxfordshire research database team. Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011. J Antimicrob Chemother 67(6):1514\u20131524. https:\/\/doi.org\/10.1093\/jac\/dks082","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"4423_CR15","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1101\/gr.216606.116","volume":"27","author":"T Kallonen","year":"2017","unstructured":"Kallonen T, Brodrick HJ, Harri SR, Corander J, Brown NM, Martin V et al (2017) Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131. Genome Res 27(8):1437\u20131449. https:\/\/doi.org\/10.1101\/gr.216606.116","journal-title":"Genome Res"},{"issue":"3","key":"4423_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1159\/000439441","volume":"95","author":"J Medina-Polo","year":"2015","unstructured":"Medina-Polo J, Arr\u00e9bola-Pajares A, P\u00e9rez-Cadavid S, Ben\u00edtez-Sala R, Sope\u00f1a-Sutil R, Lara-Isla A et al (2015) Extended-spectrum beta-lactamase-producing bacteria in a urology ward: epidemiology, risk factors and antimicrobial susceptibility patterns. Urol Int 95(3):288\u2013292. https:\/\/doi.org\/10.1159\/000439441","journal-title":"Urol Int"},{"issue":"1","key":"4423_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12879-017-2395-8","volume":"17","author":"J Manyahi","year":"2017","unstructured":"Manyahi J, Moyo SJ, Tellevik MG, Ndugulile F, Urassa W, Blomberg B et al (2017) Detection of CTX-M-15 beta-lactamases in Enterobacteriaceae causing hospital- and community-acquired urinary tract infections as early as 2004, in Dar Es Salaam, Tanzania. BMC Infect Dis 17(1):282. https:\/\/doi.org\/10.1186\/s12879-017-2395-8","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4423_CR18","doi-asserted-by":"publisher","first-page":"e1006496","DOI":"10.1371\/journal.pcbi.1006496","volume":"15","author":"A Duva","year":"2019","unstructured":"Duva A, Obadia T, Bo\u00eblle P-Y, Fleury E, Herrmann J-L, Guillemot D et al (2019) Close proximity interactions support transmission of ESBL-K. pneumoniae but not ESBL-E. coli in healthcare settings. PLoS Comput Biol 15(5):e1006496. https:\/\/doi.org\/10.1371\/journal.pcbi.1006496","journal-title":"PLoS Comput Biol"},{"key":"4423_CR19","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.2147\/IDR.S269989","volume":"13","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, Hang Y, Chen Y, Fang X, Cao X, Hu X et al (2020) A retrospective analysis of risk factors and patient outcomes of bloodstream infection with extended-spectrum \u03b2-lactamase-producing Escherichia coli in a Chinese tertiary hospital. Infect Drug Resist. 13:4289\u20134296. https:\/\/doi.org\/10.2147\/IDR.S269989","journal-title":"Infect Drug Resist."},{"key":"4423_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104315","volume":"93","author":"Q Chen","year":"2021","unstructured":"Chen Q, Ma G, Cao H, Yang X, Jiang Y (2021) Risk factors and diagnostic markers for Escherichia coli bloodstream infection in older patients. Arch Gerontol Geriatr 93:104315. https:\/\/doi.org\/10.1016\/j.archger.2020.104315","journal-title":"Arch Gerontol Geriatr"},{"key":"4423_CR21","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.3389\/fmicb.2019.01676","volume":"10","author":"S Iacob","year":"2019","unstructured":"Iacob S, Iacob DG (2019) Infectious threats, the intestinal barrier, and its Trojan horse: dysbiosis. Front Microbiol 10:1676. https:\/\/doi.org\/10.3389\/fmicb.2019.01676","journal-title":"Front Microbiol"},{"issue":"4","key":"4423_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ijantimicag.2018.12.006","volume":"53","author":"P Piewngam","year":"2019","unstructured":"Piewngam P, Qui\u00f1ones M, Thirakittiwatthana W, Yungyuen T, Otto M, Kiratisin P (2019) Composition of the intestinal microbiota in extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae carriers and non-carriers in Thailand. Int J Antimicrob Agents 53(4):435\u2013441. https:\/\/doi.org\/10.1016\/j.ijantimicag.2018.12.006","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"4423_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/jac\/dkm318","volume":"60","author":"MJ Schwaber","year":"2007","unstructured":"Schwaber MJ, Carmeli Y (2007) Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60(5):913\u2013920. https:\/\/doi.org\/10.1093\/jac\/dkm318","journal-title":"J Antimicrob Chemother"},{"key":"4423_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/IDR.S192072","volume":"12","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Gao HY, Li D, Li Z, Qi SS, Zheng S et al (2019) Clinical outcome of Escherichia coli bloodstream infection in cancer patients with\/without biofilm formation: a single-center retrospective study. Infect Drug Resist 12:359\u2013371. https:\/\/doi.org\/10.2147\/IDR.S192072","journal-title":"Infect Drug Resist"},{"key":"4423_CR25","doi-asserted-by":"publisher","first-page":"205873842094237","DOI":"10.1177\/2058738420942375","volume":"34","author":"FC Chen","year":"2020","unstructured":"Chen FC, Ho YN, Cheng HH, Wu CH, Change MW, Su CM (2020) Does inappropriate initial antibiotic therapy affect in-hospital mortality of patients in the emergency department with Escherichia coli and Klebsiella pneumoniae bloodstream infections? Int J Immunopathol Pharmacol 34:2058738420942375. https:\/\/doi.org\/10.1177\/2058738420942375","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4423_CR26","doi-asserted-by":"publisher","unstructured":"Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J  CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2(3):145\u2013152. https:\/\/doi.org\/10.1038\/sj.gene.6363752","DOI":"10.1038\/sj.gene.6363752"},{"issue":"11","key":"4423_CR27","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML et al (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of graves\u2019 disease. J Immunol 165(11):6606\u20136611. https:\/\/doi.org\/10.4049\/jimmunol.165.11.6606","journal-title":"J Immunol"},{"key":"4423_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.gene.2018.11.027","volume":"687","author":"P Qiu","year":"2019","unstructured":"Qiu P, Wang L, Ni J, Zhang Y (2019) Associations between HMGB1 gene polymorphisms and susceptibility and clinical outcomes in Chinese Han sepsis patients. Gene. 687:23\u201329. https:\/\/doi.org\/10.1016\/j.gene.2018.11.027","journal-title":"Gene."},{"key":"4423_CR29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fimmu.2019.00085","volume":"10","author":"M Mussbacher","year":"2019","unstructured":"Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H et al (2019) Cell type-specific roles of NF-\u03baB linking inflammation and thrombosis. Front Immunol 10:85. https:\/\/doi.org\/10.3389\/fimmu.2019.00085","journal-title":"Front Immunol"},{"issue":"4","key":"4423_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.immuni.2014.01.013","volume":"40","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Lu Y, Ma L, Cao X, Xiao J, Chen J et al (2014) Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-\u03baB signaling and protects against endotoxin shock. Immunity. 40(4):501\u2013514. https:\/\/doi.org\/10.1016\/j.immuni.2014.01.013","journal-title":"Immunity."},{"issue":"1","key":"4423_CR31","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1186\/s12889-018-6013-5","volume":"18","author":"L Tian","year":"2018","unstructured":"Tian L, Sun Z, Zhang Z (2018) Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health 18(1):1121. https:\/\/doi.org\/10.1186\/s12889-018-6013-5","journal-title":"BMC Public Health"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-022-04423-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-022-04423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T11:07:26Z","timestamp":1650625646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-022-04423-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["4423"],"URL":"https:\/\/doi.org\/10.1007\/s10096-022-04423-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"12 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol was approved by the ethics committee of the Second Affiliated Hospital of Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was acquired from each patient involved in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}